State-of-the-art Facilities: Designed With Quality In Mind
SCA features state-of-the-art production facilities in both Arkansas and Connecticut.
Our new 90,000 square foot production facility located in Windsor, CT opened in November 2017. This cutting edge facility features progressive design elements to facilitate quicker turnaround times and enhance our customers’ experience.
“We are very pleased to be able to serve our great customers who have trusted us and allowed SCA Pharma to become one of the nation’s largest 503B outsourcing companies,” expressed CEO Milton Boyer. “We believe this investment in Connecticut will allow us to meet the needs of our current customers and patients alike as we continue our rapid growth.”
How to Properly Decipher an FDA Form 483
In your role, you’re likely responsible for vetting potential supplier partners on behalf of your hospital or GPO.…
The Advantages of 503B Compounding
Due to the important role of healthcare in maintaining the health of the general public in society, it…
What the FDA is Finding Industry Wide During 503B Inspections
Please Note: The following article pertains to industry wide Inspections and is not representative of SCA Pharma. The…
Milton Boyer
Mr. Boyer has served in technical, commercial and executive roles in the pharmaceutical industry for more than 25 years with a specific focus in contract…
Grace Breen
Grace brings over 30 years of experience in the pharmaceutical industry to SCA, previously holding global leadership positions at Impax, Hospira and Catalent Pharma Solutions.…
Seth Traub
Seth has dedicated his career to producing quality products at the right price, and providing unparalleled customer service and on-time delivery. He has introduced and…
Michelle Wood
Michelle Wood is responsible for leading SCA sales and customers service teams, negotiating GPO/IDN contracts, and increasing brand awareness nationwide. Michelle has over 10 years…